|
(b)(4).A manufacturing record evaluation was performed for the finished device qbmhsz batch number, and no non-conformances were identified.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, gender, weight, bmi at the time of index procedure.Date of the index surgical procedure? the diagnosis and indication for the index surgical procedure? what was the onset date of necrosis following the index surgery? did the patient experience an infection? if yes, were cultures performed? results? date the debridement and reapproximation were performed? what was the appearance of the monocryl suture during the second procedure? where and how was the dermabond device used (what layer of tissue and how many layers applied)? was a dressing applied over the dermabond? if yes, please describe, including brand name.How many days post-op was the dressing in place? what was the frequency of dressing changes? has the patient had prior exposure to dermabond, prineo or skin adhesives? lot number of dermabond used.Other relevant patient history / concomitant medications? if applicable, will product be returned? what is the patient¿s current status? note: event related to topical skin adhesive reported via mw# 2210968-2020-07103.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|